In one paragraphArticle in American journal of respiratory cell and molecular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
25 authors.
Oanh N HoangDepartment of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.ORCID 0000-0001-5304-585X Colin E ChanDepartment of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.ORCID 0000-0002-7014-497X Joshua M BrennerDepartment of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.ORCID 0000-0001-8656-3872 Denisse Leza-RinconDepartment of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Ana M JaramilloDivision of Pulmonary Sciences and Critical Care Medicine, University of Colorado School of Medicine, Aurora, CO, United States.ORCID 0000-0001-8089-4275 Brendan DolanDepartment of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, Sweden.ORCID 0000-0001-9062-3882 Adam W AzizDepartment of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Rodolfo A CardenasDepartment of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Gerardo J CardenasDepartment of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Eduardo D GalvezDepartment of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.ORCID 0009-0009-6640-9873 Joshua B HalesDepartment of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.ORCID 0000-0003-1122-3990 Emilia S Nunez-PenaDepartment of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.ORCID 0000-0001-7295-0898 Boxuan YangDepartment of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.ORCID 0000-0002-3333-175X Reid T PowellInstitute of Biosciences and Technology, Texas A&M School of Medicine, Houston, TX, United States.ORCID 0000-0002-6242-8315 Leoncio VergaraInstitute of Biosciences and Technology, Texas A&M School of Medicine, Houston, TX, United States.ORCID 0000-0001-7427-9567 Harry Karmouty-QuintanaDepartment of Biochemistry and Molecular Biology and Division of Pulmonary, Critical Care, and Sleep Medicine, University of Texas Health Science Center at Houston, Houston, TX, United States.ORCID 0000-0003-4753-9823 Jesper M MagnussonDepartment of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, Sweden.ORCID 0000-0002-5630-0155 Gunnar C HanssonDepartment of Medical Biochemistry and Cell Biology, University of Gothenburg, Gothenburg, Sweden.ORCID 0000-0002-1900-1869 Roberto AdachiDepartment of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.ORCID 0000-0002-0146-0768 John D DickinsonDepartment of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, United States.ORCID 0000-0001-5184-9184 Christopher M EvansDivision of Pulmonary Sciences and Critical Care Medicine, University of Colorado School of Medicine, Aurora, CO, United States.ORCID 0000-0001-5600-7314 Michael J TuvimDepartment of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.ORCID 0000-0001-8126-7716 Burton F DickeyDepartment of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.ORCID 0000-0002-4780-1847 Funding
Research Programming ModuleP30EY007551 · NEI · UNIVERSITY OF HOUSTON · PI Nimesh Bhikhu Patel · 1988 to 2026
$16.4MTargeting early events in MUC5B-driven lung injury and fibrosisP01HL162607 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI David Albert Schwartz · 2023 to 2026
$12.4MRole of Mucin in Lung Homeostasis and PathophysiologyR01HL080396 · NHLBI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Christopher M Evans · 2009 to 2026
$8.6MMechanisms of lung macrophage programming by MUC5B during health and diseaseR01HL130938 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI EVANS, CHRISTOPHER M · 2016 to 2025
$5.2MControlling the core airway mucin secretion machinery to prevent pathophysiologyR01HL129795 · NHLBI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DICKEY, BURTON F · 2015 to 2023
$3.8MSineoculis Homeobox Homolog 1 (Six1) in Pulmonary FibrosisR01HL157100 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI KARMOUTY-QUINTANA, HARRY · 2021 to 2025
$2.8M3'UTR Shortening In Pulmonary Vascular DiseaseR01HL138510 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI KARMOUTY-QUINTANA, HARRY · 2017 to 2021
$2.3MFunction and Regulation of Airway Mucin GlycosylationR01HL179623 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI Christopher M Evans · 2025 to 2026
$1.4MMucin Biosynthesis and Transport Mechanisms in Respiratory Health and DiseaseR00HL165072 · NHLBI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Ana Maria Jaramillo Hernandez · 2025 to 2026
$498kMucin Biosynthesis and Transport Mechanisms in Respiratory Health and DiseaseK99HL165072 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI JARAMILLO HERNANDEZ, ANA MARIA · 2023 to 2024
$219kBLRD VA I01 BX005343BLRD VA IK2 BX006462Cystic Fibrosis Foundation DICKEY18G0Cystic Fibrosis Foundation DICKEY19P0Cystic Fibrosis Foundation DICKEY24P0Cystic Fibrosis Foundation JARAMI20F0Knut and Alice Wallenberg Foundation 2017-0028NEI NIH HHS P30 EY007551NHLBI NIH HHS K99 HL165072NHLBI NIH HHS P01 HL162607NHLBI NIH HHS R00 HL165072NHLBI NIH HHS R01 HL080396NHLBI NIH HHS R01 HL129795NHLBI NIH HHS R01 HL130938NHLBI NIH HHS R01 HL138510NHLBI NIH HHS R01 HL157100NHLBI NIH HHS R01 HL179623NIH HHS K99 HL165072NIH HHS P01 HL162607NIH HHS P30 EY007551NIH HHS R01 HL080396NIH HHS R01 HL129795NIH HHS R01 HL130938NIH HHS R01 HL138510NIH HHS R01 HL157100NIH HHS R01 HL179623Swedish Cystic Fibrosis FoundationSwedish Research Council 2023-02474US Department of Veterans Affairs I01BX005343US Department of Veterans Affairs IK2BX006462
6 · The paper itselfAbstract
rationaleFinely tuned production and secretion of the polymeric mucins MUC5AC and MUCB are required for lung health, but knowledge of many details between their translation and their packaging into secretory granules is lacking.
objectivesTo analyze the structure and function of the Golgi apparatus, a key site of mucin glycosylation, folding, polymerization, and packaging, in airway epithelial secretory cells.
methodsLung tissue was obtained from mice stimulated or not with IL-13 to upregulate mucin production and from normal human lungs. Golgi elements in mouse and human tissue were imaged by high-resolution immunofluorescence microscopy and electron microscopy. Tissue from mice with deletion of both polymeric mucins was also examined. MEASUREMENTS AND MAIN
resultsBy immunofluorescence microscopy, both mouse and human airway secretory cells contained approximately 100 dispersed puncta labeled by markers of medial and trans-Golgi cisternae and the trans-Golgi network (TGN), but only a few perinuclear puncta were labeled by markers of cis-Golgi cisternae. By electron microscopy, secretory cells contained both a perinuclear Golgi ribbon and numerous dispersed Golgi stacks, termed satellites. In mucous metaplastic cells, satellites were concentrated among immature mucin granules. Increasing mucin production by cytokine stimulation did not increase the number of TGN puncta, nor did preventing polymeric mucin production by gene deletion reduce TGN puncta.
conclusionsMucin-producing airway secretory cells express an unusual Golgi structure consisting of a conventional perinuclear ribbon as well as dispersed satellites. While the Golgi satellites are likely an adaptation for mucin production and packaging, their presence is specified developmentally, independent of mucin production.
Indexed as
Epithelial CellsGolgi ApparatusLungAnimalsHumansInterleukin-13MiceMucin 5ACMucin-5BInterleukin-13MUC5AC protein, humanMuc5ac protein, mouseMUC5B protein, humanMuc5b protein, mouseMucin 5ACMucin-5BGolgiMUC5ACMUC5Bmucinmucus
Identifiers
PMID41738292
PMCPMC13296370
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390